Skip to content

Characteristics of Constitution Distribution in Phlegm-Dampness MAFLD Patients and Its Correlation with Clinical Features

Characteristics of Constitution Distribution in Phlegm-Dampness MAFLD Patients and Its Correlation with Clinical Features

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001555
Enrollment
Unknown
Registered
2025-08-14
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic-associated fatty liver disease

Interventions

Phlegm-Dampness Constitution Group:No
NO-Phlegm-Dampness Constitution Group:NO

Sponsors

People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1 Meeting the diagnostic criteria for metabolic dysfunction-associated fatty liver disease (MAFLD) 2 Aged 18–65 years voluntarily provided written informed consent and able to cooperate with: (1)Collection of general demographic data (2)Completion of standardized questionnaires (3)Accurate documentation of symptom profiles (4)Provision of complete and reliable medical records

Exclusion criteria

Exclusion criteria: (1)Patients with severe heart lung liver or kidney failure or advanced-stage malignancies (2)Alcohol-related fatty liver disease or mixed-type fatty liver disease (3)Acute hepatitis severe hepatitis decompensated cirrhosis or hepatocellular carcinoma (HCC) (4)Patients with specific diseases that may cause fatty liver including: Viral hepatitis Drug-induced liver injury Total parenteral nutrition (TPN)-associated steatosis Wilsons disease Autoimmune liver diseases Pregnant or lactating women those planning pregnancy in the near future individuals using estrogen-based contraceptives or patients with psychiatric disorders

Design outcomes

Secondary

MeasureTime frame
waist circumference;Body weight;Height;Alcohol and Tobacco Use History;urea nitrogen;Urinary albumin creatinine ratio;Complete Blood Count + C-Reactive Protein (CRP);comorbidity;uric acid;Information from TCM's Four Diagnostic Techniques;estimated glomerular filtration rate;Age;Gender;Body mass index;Blood creatinine;blood presure;Medical history;

Primary

MeasureTime frame
NAFLD Fibrosis Score;total protein;glycosylated hemoglobin;Aspartate Aminotransferase;Fibrosis-4 Index;Homeostasis Model Assessment of Insulin Resistance;Fasting blood glucose;total bilirubin;albumin;Alanine Aminotransferase;Serum lipids;Fasting insulin;

Countries

China

Contacts

Public ContactMingqian Jiang

People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine

JMQian1130@hotmail.com18850351500

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026